Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2006 2
2010 2
2011 1
2012 3
2013 1
2014 5
2015 1
2016 1
2017 1
2018 2
2019 2
2020 4
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
PERISCOPE: road towards effective control of pertussis.
PERISCOPE Consortium. PERISCOPE Consortium. Lancet Infect Dis. 2019 May;19(5):e179-e186. doi: 10.1016/S1473-3099(18)30646-7. Epub 2018 Nov 28. Lancet Infect Dis. 2019. PMID: 30503084 Review.
Live attenuated vaccines against pertussis.
Locht C, Mielcarek N. Locht C, et al. Among authors: mielcarek n. Expert Rev Vaccines. 2014 Sep;13(9):1147-58. doi: 10.1586/14760584.2014.942222. Epub 2014 Aug 1. Expert Rev Vaccines. 2014. PMID: 25085735 Review.
The ins and outs of pertussis toxin.
Locht C, Coutte L, Mielcarek N. Locht C, et al. Among authors: mielcarek n. FEBS J. 2011 Dec;278(23):4668-82. doi: 10.1111/j.1742-4658.2011.08237.x. Epub 2011 Aug 4. FEBS J. 2011. PMID: 21740523 Free article. Review.
New pertussis vaccination approaches: en route to protect newborns?
Locht C, Mielcarek N. Locht C, et al. Among authors: mielcarek n. FEMS Immunol Med Microbiol. 2012 Nov;66(2):121-33. doi: 10.1111/j.1574-695X.2012.00988.x. Epub 2012 Jun 13. FEMS Immunol Med Microbiol. 2012. PMID: 22574832 Free article. Review.
Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
Castro JT, Oliveira GS, Nishigasako MA, Debrie AS, Miyaji EN, Soares-Schanoski A, Akamatsu MA, Locht C, Ho PL, Mielcarek N, Oliveira MLS. Castro JT, et al. Among authors: mielcarek n. PLoS One. 2020 Jan 16;15(1):e0228055. doi: 10.1371/journal.pone.0228055. eCollection 2020. PLoS One. 2020. PMID: 31945121 Free PMC article.
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team. Jahnmatz M, et al. Among authors: mielcarek n. Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17. Lancet Infect Dis. 2020. PMID: 32687804 Clinical Trial.
29 results